Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longitudinal study);Prognostische bedeutung der physikalischen streßechokardiographie bei 3329 ambulanten patienten (5jährige langzeitstudie)

Journal fur Kardiologie

Volumn 12, Issue 11-12, 2005, Pages 292-302

  Leischik, R ^a,c   Dworrak, B ^a   Littwitz, H ^a   Gulker H ^a,b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b HELIOS KLINIKUM WUPPERTAL   (Germany)

^c NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; EXERCISE TEST; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT; PREDICTION; PROGNOSIS; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY; THORAX PAIN;

EID: 30944438882     PISSN: 10240098     EISSN: 1680936X     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Erbel R. The dawn of a new area. Herz 1996; 21: 75-7.
2. Leischik R, Adamczewski O, Pötter S, Erbel R, Lösse B. Exercise echocardiography - a new test for the assessment of antiischemic drug effects. Z Kardiol 1995; 84: 621-32.
3. Nesto RW, Kowalchuck GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expression of ischemia. Am J Cardiol 1987; 57: 23C-27C.
4. Armstrong WF, Pellikka P, Ryan T, Crouse L, Zoghbi WA. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Am J Soc Echocardiogr 1998; 11: 97-104.
5. Cheitlin MD, Armstrong WF, Aurigemma PG, Beller GA, Bierman FZ, Davis JL, Douglas PS, Faxon DP, Gillam LD, Kimball TR, Kussmaul WG, Pearlman AS, Philbrick JT, Rakowski H, Thys DM Antman EM, Smith Jr SC, Alpert JS, Grogoratus G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. J Am Soc Echocardiogr 2003; 16: 1091-100.
6. Leischik R, Erbel R. Streß-Echokardiographie. pmi Verlagsgruppe GmbH, Frankfurt/M., 1997.
7. Hoffmann R, Lethen H, Marwick TH, Rambaldi R, Fioretti P, Pingitore A, Picano E, Buck T, Erbel R, Flachskampf FA, Hanrath P. Standardized guidelines for the interpretation of dobutamine echocardiography reduce interinstitutional variance in interpretation. J Am Coll Cardiol 1998; 82: 1520-4.
8. Leischik R, Eising EG, Katz M, Glattki G, Bruch C, Seeber S, Bockisch A, Erbel R. Comparison of stress echocardiography and radionuclide ventriculography in the diagnosis of cardiomyopathy in patients receiving chemotherapy for malignant diseases. Dtsch Med Wochenschr 1997; 122: 1509-15.
9. Schwammenthal E, Schwartzkopff B, Block M, Johns J, Lösse B, Engberding R, Borggrefe M, Breithardt G. Doppler echocardiographic assessment of the pressure gradient during bicycle ergometry in hypertrophic cardiomyopathy. Am J Cardiol 1992; 69: 1623-8.
10. Nixdorff U, Wagner ST, Erbel R, Mohr-Kahaly S, Weitzel P, Rieger K, Meyer J. Dobutamine stress Doppler echocardiography: reproducibility and physiologic left ventricular filling patterns. Int J Cardiol 1997; 58: 293-303.
11. Leischik R, Bartel T, Möhlenkamp S, Bruch C, Buck T, Haude M, Görge G, Erbel R. Stress echocardiography: new techniques. Eur Heart J 1997; 18 (Suppl D): D49-D56.
12. Leischik R, Kuhlmann C, Bruch C, Jeremias A, Buck T, Erbel R. Reproducibility of stress echocardiography using intravenous injection of ultrasound contrast agent (BY 963). Int J Card Imaging 1997; 13: 387-94.
13. Senior R, Soman P, Khattar RS, Lahiri A. Improved endocardial visualization with second harmonic imaging compared with fundamental two-dimensional echocardiographic imaging. Am Heart J 1999; 138: 163-8.
14. Yokoyama N, Schwarz KQ, Steinmetz SD, Li X, Chen X. Prognostic value of contrast stress echocardiography in patients with image quality too limited for traditional noncontrast harmonic echocardiography. J Am Soc Echocardiogr 2004; 17: 15-20.
15. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnitiger L, Silverman NH, Tajik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-67.
16. Marwick TH, Mehta R, Arheart K, Lauer MS. Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol 1997; 30: 83-90.
17. Bruce RA. Methods of exercise testing. Am J Cardiol 1974; 33: 715.
18. Podrid PJ, Graboys TB, Lown B. Prognosis of medically treated patients with coronary-artery disease with profound ST-segment depression during exercise testing. N Engl J Med 1981; 305: 1111-6.
19. Altman DG. Practical statistics for medical research. Chapman & Hall/CRC, London, 1999.
20. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, Friedman JD, Germano G, Van Train K, Diamond GA. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26: 639-47.
21. Colon PJ, Mobarek SK, Milani RV, Lavie CJ, Cassidy MM, Murgo, JP, Cheirif J. Prognostic value of stress echocardiography in the evaluation of atypical chest pain patients without known coronary artery disease. Am J Cardiol 1998; 81: 545-51.
22. Shaw LJ, Hachamovitch R, Berman DS, Marwick TH, Lauer MS, Heller GV, Iskandrian AE, Kesler KL, Travin MI, Lewin HC, Hendel RC, Borges-Neto S, Miller DD. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. J Am Coll Cardiol 1999; 33: 661-9.
23. Poldermans D, Fioretti PM, Boersma E, Cornel JH, Borst F, Vermeulen EGJ, Arnese M, Elhendy A, Roelandt JRTC. Dobutamine atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease. Am J Med 1994; 97: 119-25.
24. Severino S, D'Andrea A, Caso P, Celentano E, DeSimone L, Liccardo B, Morra P, Cicala S, Astarita C, Mininni N. Long-term prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease. Ital Heart J 2001; 2: 256-64.
25. Machecourt J, Longère P, Farget D, Vanzetto G, Wolf JE, Polidori C, Comet M, Denis B. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect. J Am Coll Cardiol 1994; 23: 1096-106.
26. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, McArthur D, Froelicher V. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989; 80: 87-98.
27. Mark DB, Hlatky MA, Harrell FE, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987; 106: 793-800.
28. Weiner DA, Ryan TJ, McCabe CH, Chaitman BR, Sheffield LT, Ferguson JG, Fisher LD, Tristani F. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol 1984; 3: 772-9.
29. Gohlke H, Samek L, Betz P, Roskamm H. Exercise testing provides additional prognostic information in angiographically defined subgroups of patients with coronary artery disease. Circulation 1983; 68: 979-85.
30. Dagenais GR, Rouleau JR, Hochart P, Magrina J, Cantin B, Durnesnil JG. Survival with painless strongly positive exercise electrocardiogram. Am J Cardiol 1988; 62: 892-5.
31. Bigi R, Galati A, Curti G, Coletta C, Partesana N, Bordi L, Barlera S, Ceci V, Occhi G, Fiorentini C. Prognostic value of residual ischemia assessed by means of exercise echocardiography and dobutamine stress echocardiography after uncomplicated myocardial infarction. Eur Heart J 1997; 18: 1873-81.
32. Vilella A, Maggioni A, Vilella M, on behalf of the GISSI investigators. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data base. Lancet 1995; 346: 523-9.
33. Fioretti P, Brower RW, Simoons ML, TenKaten H, Beelen A, Baardman T, Lubsen J, Hugenholtz PG. Relative value of clinical variables, bicycle ergometry, rest radionuclide ventriculography and 24 hour ambulatory electrocardiographic monitoring at discharge to predict 1 year survival after myocardial infarction. J Am Coll Cardiol 1986; 8: 40-9.
34. 201TI, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation 1998; 98: 2679-86.
35. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 310-8.
36. Davies MJ. Detecting vulnerable plaques. Lancet 1996; 47: 1422-3.
37. Grüntzig AR, Senning A, Siegenthaler WE. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. N Engl J Med 1979; 301: 61-8.
38. Holmes DR. State of the art in coronary intervention. Am J Cardiol 2003; 91: 50-3.
39. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levin TH, Pepine CJ, Schaeffer JW, Smith III EE, Steward DE, Theroux P. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - 2002: summary article. Circulation 2002; 106: 1893-900.
40. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-7.
41. Schwitter J, Nanz D, Kneifel S, Bertschinger K, Büchi M, Knüsel PR, Marincek B, Lüscher TF, Von Schulthess GK. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance. Circulation 2001; 103: 2230-5.